Targeted cancer therapy based on blocking the expression of genes and small doses of oxaliplatin.

Poster   Apr 01, 2014

 
Targeted cancer therapy based on blocking the expression of genes and small doses of oxaliplatin.
 
View Poster
 
 

Bavykin A.S.1, Korotaeva A.A.1, Poyarkov S.V.2, Syrtsev A.V.1, Karpukhin A.V.1

 
 

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

 
View Poster
 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Cell Science Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

OTHER POSTERS


Applications of chemically modified synthetic guide RNA for CRISPR-Cas9 genome editing

Poster

Our results indicate that MS modifications are required for experiments with co-electroporation of Cas9 mRNA and synthetic gRNA, yet have no impact on editing efficiency when delivered with lipid-based transfection reagents.

READ MORE

Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell Lines

Poster

Inecalcitol is a vitamin D receptor agonist currently in Phase II clinical trial in AML (acute myeloid leukemia). Inecalcitol increases the expression of CD38 at the surface of 5 multiple myeloma cell lines; therefore, inecalcitol could potentiate the clinical response of MM patients to a therapeutic anti-CD38 antibody
Inecalcitol induces the expression of the CD38 antigen at the surface of 4 AML cell lines; thus, inecalcitol could render AML patients sensitive to a therapeutic anti-CD38.

READ MORE

 

Comments | 0 ADD COMMENT